Oculis Holding AG Research and Development Expense
Oculis Holding AG (OCS) reported Research and Development Expense of CHF 57.09 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-04.
Financial Statements › Expense Statement › Operating Expenses
ifrs-full:ResearchAndDevelopmentExpense · last filed 2026-03-04
- Oculis Holding AG research and development expense for the quarter ending 2025-06-30 was 14.91M CHF, a 9.45% decline year-over-year.
- Oculis Holding AG research and development expense for the quarter ending 2024-06-30 was 16.46M CHF, a 165.65% increase year-over-year.
- Oculis Holding AG research and development expense for the quarter ending 2023-06-30 was 6.20M CHF.
| Period end | Research And Development Expense 3 month | Research And Development Expense 6 month | Research And Development Expense 12 month |
|---|---|---|---|
| 2025-12-31 | 57.09M CHF 20-F · filed 2026-03-04 | ||
| 2025-06-30 | 14.91M CHF 6-K · filed 2025-08-21 | 29.68M CHF 6-K · filed 2025-08-21 | |
| 2024-12-31 | 52.08M CHF 20-F · filed 2026-03-04 | ||
| 2024-06-30 | 16.46M CHF 6-K · filed 2025-08-21 | 27.32M CHF 6-K · filed 2025-08-21 | |
| 2023-12-31 | 29.25M CHF 20-F · filed 2026-03-04 | ||
| 2023-06-30 | 6.20M CHF 6-K · filed 2024-08-27 | 12.35M CHF 6-K · filed 2024-08-27 | |
| 2022-12-31 | 22.22M CHF 20-F · filed 2025-03-11 | ||
| 2021-12-31 | 9.57M CHF 20-F · filed 2024-03-19 | ||
| 2020-12-31 | 9.34M CHF 20-F · filed 2023-03-28 |